Novel strategies for the pharmacological management of type 2 diabetes

A Nourparvar, A Bulotta, U Di Mario… - Trends in Pharmacological …, 2004 - cell.com
Type 2 diabetes is characterized by high concentrations of glucose in the blood, which is
caused by decreased secretion of insulin from the pancreas and decreased insulin action …

The hot and potential targets of type 2 diabetes mellitus treatment in recent decade

Q Xu, L Wang, J Luo, D Shi - Current Drug Targets, 2018 - ingentaconnect.com
Background: Type 2 diabetes mellitus (T2DM) has been a great burden to the world and it is
urgent to develop new treatment strategies. Recently, many targets are currently available to …

Current and emerging treatment options in diabetes care

C Clemmensen, TD Müller, B Finan, MH Tschöp… - Metabolic Control, 2016 - Springer
Diabetes constitutes an increasing threat to human health, particularly in newly
industrialized and densely populated countries. Type 1 and type 2 diabetes arise from …

Advances in antidiabetic drugs targeting insulin secretion

Y Ding, Y Li, Q Chen, B Niu - Current Pharmaceutical Design, 2018 - ingentaconnect.com
Background: Diabetes mellitus (DM) is a disease of systemic metabolic disorders caused by
the decrease of secretion or sensitivity of insulin. In recent years, the study of insulin-related …

Fighting type-2 diabetes: present and future perspectives

CG Yu, Y Fu, Y Fang, N Zhang, RX Sun… - Current medicinal …, 2019 - ingentaconnect.com
Background: Type-2 diabetes mellitus accounts for 80-90% of diabetic patients. So far, the
treatment of diabetes mainly aims at elevating insulin level and lowering glucose level in the …

Diabetes mellitus in the next decade: novel pipeline medications to treat hyperglycemia

V Fonseca - Clinical therapeutics, 2013 - Elsevier
Despite a rapid increase in the number of drugs available to treat hyperglycemia there
remain several unmet needs in the prevention and treatment of diabetes. There have also …

A recent achievement in the discovery and development of novel targets for the treatment of type-2 diabetes mellitus

TM Belete - Journal of experimental pharmacology, 2020 - Taylor & Francis
Abstract Type 2 diabetes (T2DM) is a chronic metabolic disorder. Impaired insulin secretion,
enhanced hepatic glucose production, and suppressed peripheral glucose use are the main …

Novel agents for the treatment of type 2 diabetes

RA DeFronzo, CL Triplitt, M Abdul-Ghani… - Diabetes …, 2014 - Am Diabetes Assoc
In Brief Impaired insulin secretion, increased hepatic glucose production, and decreased
peripheral glucose utilization are the core defects responsible for the development and …

Novel therapeutic agents for management of diabetes mellitus: a hope for drug designing against diabetes mellitus

AME Elkhalifa, M Nazar, SI Ali, I Khursheed, S Taifa… - Life, 2024 - mdpi.com
Diabetes mellitus (DM) is characterized by an absolute decline in insulin secretion and
peripheral resistance and is the most prevalent metabolic and endocrine disorder. However …

Novel therapies with precision mechanisms for type 2 diabetes mellitus

L Perreault, JS Skyler, J Rosenstock - Nature Reviews Endocrinology, 2021 - nature.com
Type 2 diabetes mellitus (T2DM) is one of the greatest health crises of our time and its
prevalence is projected to increase by> 50% globally by 2045. Currently, 10 classes of …